Identification of an adult with compound heterozygosity that includes the first reported missense mutation suggests that we are likely to continue to find individuals with milder OI phenotypes that will expand the phenotypic range of LEPRE1-related OI. This evidence concerns the gene P3H1 and osteogenesis imperfecta.